FR2434620A1 - Composition intraveineuse a base de solution de ringer destinee au traitement de troubles cardiovasculaires - Google Patents

Composition intraveineuse a base de solution de ringer destinee au traitement de troubles cardiovasculaires

Info

Publication number
FR2434620A1
FR2434620A1 FR7921455A FR7921455A FR2434620A1 FR 2434620 A1 FR2434620 A1 FR 2434620A1 FR 7921455 A FR7921455 A FR 7921455A FR 7921455 A FR7921455 A FR 7921455A FR 2434620 A1 FR2434620 A1 FR 2434620A1
Authority
FR
France
Prior art keywords
treatment
compositions
composition based
cardiovascular disorders
relates
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7921455A
Other languages
English (en)
Other versions
FR2434620B3 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of FR2434620A1 publication Critical patent/FR2434620A1/fr
Application granted granted Critical
Publication of FR2434620B3 publication Critical patent/FR2434620B3/fr
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/55—Glands not provided for in groups A61K35/22 - A61K35/545, e.g. thyroids, parathyroids or pineal glands

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Zoology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Endocrinology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

L'invention a trait au domaine de la chimie médicale. Elle concerne des compositions nouvelles préparées à partir d'une base injectable de Ringer additionnée des ingrédients suivants : complexe B, acide chlorhydrique, ascorbate de sodium, chlorhydrate de pyridoxine, sulfate de magnésium, cortex surrénal, chlorure de magnésium, thiamine, sel de sodium de l'héparine, gluconate de calcium et de saccharate de calcium. D'autres formes de réalisation des compositions en solutions contiennent aussi de la niacine, de la vitanie B12 , de l'éther, des algues et des amino acides. Les compositions de l'invention conviennent au traitement de troubles vasculaires principalement dus à l'artériosclérose et à l'athérosclérose. Elles conviennent à l'élimination des plaques des parois intérieures artérielles et veineuses, améliorant ainsi l'irrigation des tissus corporels.
FR7921455A 1978-08-28 1979-08-27 Composition intraveineuse a base de solution de ringer destinee au traitement de troubles cardiovasculaires Granted FR2434620A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/937,533 US4167562A (en) 1978-08-28 1978-08-28 Method and composition for treating arteriosclerosis

Publications (2)

Publication Number Publication Date
FR2434620A1 true FR2434620A1 (fr) 1980-03-28
FR2434620B3 FR2434620B3 (fr) 1982-01-29

Family

ID=25470041

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7921455A Granted FR2434620A1 (fr) 1978-08-28 1979-08-27 Composition intraveineuse a base de solution de ringer destinee au traitement de troubles cardiovasculaires

Country Status (5)

Country Link
US (1) US4167562A (fr)
DE (1) DE2934718A1 (fr)
FR (1) FR2434620A1 (fr)
GB (1) GB2029218B (fr)
IL (1) IL58017A (fr)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4432975A (en) * 1981-04-13 1984-02-21 Icn Pharmaceuticals, Inc. Process for introducing vitamin B-12 into the bloodstream
FR2574663B1 (fr) * 1984-12-17 1987-01-16 Sanofi Sa Nouvelle composition therapeutique a activite antithrombotique et hypolipemiante a base de xylanes et d'un acide organique
US5248688A (en) * 1986-09-10 1993-09-28 Dudrick Medical Research Fund I, Ltd. Method and substrate composition for treating atherosclerosis
US5032608A (en) * 1986-09-10 1991-07-16 Dudrick Stanley J Method and substrate composition for treating atherosclerosis
EP0285343B1 (fr) * 1987-03-26 1994-06-29 University College London Prévention d'une ADP-ribosylation de G-protéines
US5849337A (en) * 1997-06-27 1998-12-15 Gusty Winds Corporation Method of enhancing magnesium absorption and prevention of atherosclerosis
US6043259A (en) * 1998-07-09 2000-03-28 Medicure Inc. Treatment of cardiovascular and related pathologies
EP1169322B8 (fr) 1999-03-08 2006-09-13 Medicure Inc. Analogues de pyridoxal destines aux troubles provoques par une carence en vitamine b6
AU5840200A (en) 1999-07-13 2001-01-30 Medicure Inc. Treatment of diabetes and related pathologies
EP1872797A3 (fr) 1999-08-24 2008-04-02 Medicure International Inc. Traitement des pathologies cardiovasculaires et associées
US7442689B2 (en) * 2000-02-29 2008-10-28 Medicure International Inc. Cardioprotective phosphonates and malonates
WO2001064692A1 (fr) 2000-02-29 2001-09-07 Medicure International Inc. Phosphonates et malonates cardioprotecteurs
US6586414B2 (en) 2000-03-28 2003-07-01 Medicure International Inc. Treatment of cerebrovascular disease
US6897228B2 (en) * 2000-07-07 2005-05-24 Medicure International Inc. Pyridoxine and pyridoxal analogues: new uses
ATE364595T1 (de) 2000-07-07 2007-07-15 Medicure Int Inc Pyridoxin- und pyridoxalanaloga als cardiovasculäre therapeutika
US6548519B1 (en) 2001-07-06 2003-04-15 Medicure International Inc. Pyridoxine and pyridoxal analogues: novel uses
AU2001281337A1 (en) * 2000-07-24 2002-02-05 Nutrition 21, Inc. Arginine saccharate and use thereof
US20040121988A1 (en) * 2001-03-28 2004-06-24 Medicure International Inc. Treatment of cerebrovascular disease
US20040186077A1 (en) * 2003-03-17 2004-09-23 Medicure International Inc. Novel heteroaryl phosphonates as cardioprotective agents
JP2008505126A (ja) * 2004-07-07 2008-02-21 メディキュア インターナショナル インコーポレイテッド 血小板凝集薬を用いる併用療法
US20070060549A1 (en) * 2004-08-10 2007-03-15 Friesen Albert D Combination therapies employing ace inhibitors and uses thereof for the treatment of diabetic disorders
US7459468B2 (en) * 2004-10-28 2008-12-02 Medicure International, Inc. Aryl sulfonic pyridoxines as antiplatelet agents
CA2585165A1 (fr) * 2004-10-28 2006-05-18 Medicure International Inc. Analogues de pyridoxine a double activite anti-plaquettes et anti-coagulantes
US20060094749A1 (en) * 2004-10-28 2006-05-04 Medicure International Inc. Substituted pyridoxines as anti-platelet agents
CA2632090A1 (fr) * 2005-11-28 2007-05-31 Medicure International Inc. Dosage selectionne pour le traitement de pathologies cardiovasculaires et apparentees
DE102007003524A1 (de) * 2007-01-19 2008-09-04 MEDICE Arzneimittel Pütter GmbH & Co. KG Arzneimittel zur Behandlung und/oder Prävention von Arteriosklerose
EP3791884A1 (fr) * 2019-09-16 2021-03-17 Oskar Bunz Combinaison d'héparine et sel de magnésium pour le traitement d'infections virales

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3089815A (en) * 1951-10-11 1963-05-14 Lieb Hans Injectable pharmaceutical preparation, and a method of making same
US3574831A (en) * 1968-05-29 1971-04-13 American Cyanamid Co Therapeutic heparin-sodium taurocholate compositions
US3932656A (en) * 1970-09-10 1976-01-13 Alza Corporation Article of manufacture for instant release of anti-aggregation and non-thrombogenic agents to biological media
FR2184460B1 (fr) * 1972-05-17 1975-06-20 Fabre Sa Pierre
US4039665A (en) * 1975-05-20 1977-08-02 William T. Foley Foundation, Inc. Method for the eradication of venous blemishes

Also Published As

Publication number Publication date
US4167562A (en) 1979-09-11
IL58017A (en) 1983-05-15
GB2029218A (en) 1980-03-19
GB2029218B (en) 1983-01-26
DE2934718A1 (de) 1980-03-13
FR2434620B3 (fr) 1982-01-29
IL58017A0 (en) 1979-12-30

Similar Documents

Publication Publication Date Title
FR2434620A1 (fr) Composition intraveineuse a base de solution de ringer destinee au traitement de troubles cardiovasculaires
ES2040242T3 (es) Composiciones farmaceuticas.
TNSN98019A1 (fr) Derives d'acide arylsulfonylaminohydroxamique, procede pour leur preparation et compositions pharmaceutiques les contenant.
FR2562539B1 (fr) Nouveaux derives de l'acide vinyl-4 benzoique, leur procede de preparation et leurs applications en therapeutique et comme ligands
RU97115713A (ru) Соединения, содержащие бензопиран и способ их применения
ATE377418T1 (de) Vorbeugung und behandlung von kardiovaskulären beschwerden mit tamoxifen-analogen
TNSN99156A1 (fr) Derives d'acide hydroxypipecolate-hydroxamique nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant
TNSN98036A1 (fr) Derives d'acide hexanoique nouveaux
RU95106821A (ru) Циклопептиды, способ их получения, фармацевтическая композиция и способ ее получения
FR2441627A1 (fr) Nouvelles spiro-polycyclo-imidazolidinediones et composition pharmaceutique les contenant
ATE187642T1 (de) Verwendund von norastemizol zur behandlung der allergischen rhinitis
KR960022542A (ko) 광학 활성 벤조티에핀 유도체, 그의 제조방법 및 용도
TNSN99013A1 (fr) Derives d'acide dihydroxyhexanoique nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant
FR2393577A1 (fr) Medicament a base d'acide b-(p-halogenophenyl)-g-aminobutyrique destine au traitement de la nevrose d'angoisse
RU2008131318A (ru) Новые фитинцитраты и способы их получения
ZA888160B (en) Amino acid esters,process for the preparation thereof and use thereof
CN108976285A (zh) Gly-Pro-Arg-Pro-AA修饰的华法林,其合成,活性和应用
IT8220757A0 (it) Sale di magnesio dell'acido chenodesossicolico e dell'acido ursodesossicolico, processo per lasua preparazione e composizioni terapeutiche che lo contengono come principio attivo.
TNSN01013A1 (fr) Ether-dicarboxylates de calcium, procedes pour leur preparation et traitement de maladies vasculaires et du diabete avec ces composes
FR2365340A1 (fr) Composition pharmaceutique contenant des phenylglycines l ou dl (racemiques)
FR2374899A1 (fr) Comprime destine au nettoyage automatique, en solution aqueuse, de protheses dentaires, et procede de preparation de ce comprime
FR2377446A1 (fr) Composition antimicrobienne de nettoyage de la peau
ATE147978T1 (de) Verwendung von (e) - 2 - (p -fluorophenethyl)- 3 - fluoroallylamine zur behandlung der alzheimerschen krankheit
DE708768C (de) Verfahren zur Darstellung von sauren Estern der alkylierten 1, 4-Naphthohydrochinone
FR2414055A1 (fr) Procede de preparation de l'heparine